Sandoz TV Episode 18: Trailer
Find out what to expect from the newest episode of Sandoz TV.
|Global News||Sandoz Around the World||Sandoz in the Media|
Sandoz biosimilar etanercept recommended by FDA advisory committee for approval to treat multiple inflammatory diseases
Holzkirchen, July 13, 2016
Sandoz, a Novartis division and leader in biosimilars, announced today that the US Food and Drug Administration (FDA) Arthritis Advisory Committee recommended approval of its proposed biosimilar etanercept
New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product
Holzkirchen, July 07, 2016
The EGALITY study met its primary endpoint demonstrating equivalent efficacy of Sandoz biosimilar etanercept candidate to the originator product at week 12
Dr. Harald Nusser speaks to This Week in Global Health
July 04, 2016
An interview with Dr. Harald Nusser on how Novartis Access is helping to increase access to medicines to treat non-communicable diseases (NCDs).
“Access Unplugged”: We have the opportunity – and the duty – to lead the global debate
June 29, 2016
Sandoz has a responsibility to drive access to medicines, which has always been central to our value proposition, and to help lead the public debate about the best ways of addressing global healthcare challenges.
Competing sustainably in biosimilars – more than just a numbers game
Holzkirchen, June 24, 2016
Following the Biosimilars Media Day in Schaftenau, Austria, Carol Lynch comments on what it will take to succeed in the global biosimilars market.